Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seventeen ratings firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and ten have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $43.19.
Several research firms recently commented on BBWI. TD Cowen lifted their price objective on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. Argus reissued a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Morgan Stanley cut their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Finally, JPMorgan Chase & Co. increased their price target on Bath & Body Works from $39.00 to $41.00 and gave the company a “neutral” rating in a report on Friday, January 24th.
View Our Latest Report on Bath & Body Works
Bath & Body Works Stock Down 3.5 %
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same period last year, the business posted $0.48 EPS. The company’s revenue was up 3.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Bath & Body Works will post 3.26 earnings per share for the current year.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. Creative Planning boosted its stake in Bath & Body Works by 8.1% in the 2nd quarter. Creative Planning now owns 16,648 shares of the company’s stock worth $650,000 after purchasing an additional 1,254 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Bath & Body Works by 34.4% in the third quarter. GAMMA Investing LLC now owns 2,481 shares of the company’s stock worth $79,000 after buying an additional 635 shares in the last quarter. CWM LLC boosted its position in shares of Bath & Body Works by 255.3% during the third quarter. CWM LLC now owns 18,022 shares of the company’s stock worth $575,000 after acquiring an additional 12,950 shares during the last quarter. Northwest Bank & Trust Co grew its stake in Bath & Body Works by 6.9% during the third quarter. Northwest Bank & Trust Co now owns 14,281 shares of the company’s stock valued at $456,000 after acquiring an additional 923 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its holdings in Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- What is a SEC Filing?
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- How to Invest in Biotech Stocks
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.